Augustine Lawlor
Insider
First SEC filing: March 18, 2026 · Latest: March 18, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 28, 2025 | CYPH | M | 22,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 28, 2025 | CYPH | F | 7,797 | $0.32 | $2,495 | 19,789 Direct | -28.26% | Disposed | 846.9% (price as of 2026-10-02) |
| March 28, 2025 | CYPH | M | 22,500 | · | · | 27,586 Direct | +442.39% | Acquired | (price as of 2026-10-02) |
| Nov. 13, 2024 | CYPH | X | 2,136 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 13, 2024 | CYPH | X | 2,136 | $2.82 | $6,024 | 678,456 Indirect | +0.32% | Acquired | 7.4% (price as of 2026-10-02) |
| Oct. 2, 2024 | CYPH | A | 85,000 | · | · | 85,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 29, 2024 | CYPH | A | 85,000 | · | · | 85,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 26, 2024 | CYPH | M | 5,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 26, 2024 | CYPH | M | 5,000 | · | · | 5,086 Direct | +5813.95% | Acquired | (price as of 2026-10-02) |
| Aug. 31, 2023 | GYRE | D | 24 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 31, 2023 | GYRE | D | 25 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 23, 2023 | CYPH | A | 70,000 | · | · | 70,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2023 | CYPH | A | 500,000 | · | · | 500,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2022 | CYPH | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2022 | CYPH | A | 225,000 | · | · | 225,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2021 | GYRE | A | 5,839 | · | · | 24,573 Direct | +31.17% | Acquired | (price as of 2026-10-02) |
| July 1, 2021 | GYRE | A | 5,542 | · | · | 18,734 Direct | +42.01% | Acquired | (price as of 2026-10-02) |
| June 9, 2021 | GYRE | A | 14,000 | · | · | 14,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 26, 2021 | CYPH | A | 30,000 | · | · | 30,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2021 | GYRE | A | 4,761 | · | · | 13,192 Direct | +56.47% | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2021 | CYPH | F | 11,544 | · | · | 11,544 Indirect | · | Acquired | (price as of 2026-10-02) |
| Feb. 9, 2021 | CYPH | J | 571,428 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 26, 2021 | CYPH | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 26, 2021 | CYPH | A | 150,000 | · | · | 150,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2021 | GYRE | A | 3,417 | · | · | 8,431 Direct | +68.15% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2020 | GYRE | A | 5,014 | · | · | 5,014 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 10, 2020 | CYPH | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 1, 2020 | GYRE | A | 3,673 | · | · | 24,215 Direct | +17.88% | Acquired | (price as of 2026-10-02) |
| June 11, 2020 | GYRE | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 9, 2020 | CYPH | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2020 | GYRE | A | 4,934 | · | · | 20,542 Direct | +31.61% | Acquired | (price as of 2026-10-02) |
| Feb. 25, 2020 | GYRE | S | 69,401 | $6.10 | $423,346 | 0 Indirect | -100.00% | Disposed | -92.2% (price as of 2026-10-02) |
| Jan. 2, 2020 | GYRE | A | 3,166 | · | · | 15,608 Direct | +25.45% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2019 | GYRE | A | 4,391 | · | · | 12,442 Direct | +54.54% | Acquired | (price as of 2026-10-02) |
| July 1, 2019 | GYRE | A | 2,905 | · | · | 8,051 Direct | +56.45% | Acquired | (price as of 2026-10-02) |
| June 13, 2019 | GYRE | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 11, 2019 | CYPH | A | 200,000 | · | · | 200,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 1, 2019 | GYRE | A | 2,414 | · | · | 5,146 Direct | +88.36% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2019 | CYPH | P | 571,428 | · | · | 592,797 Indirect | +2674.10% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2019 | CYPH | P | 571,428 | $1.75 | $999,999 | 4,114,804 Indirect | +16.13% | Acquired | -82.7% (price as of 2026-10-02) |
| Jan. 1, 2019 | CYPH | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2018 | GYRE | A | 2,732 | · | · | 2,732 Direct | · | Acquired | (price as of 2026-10-02) |
| July 30, 2018 | CYPH | J | 21,369 | · | · | 21,369 Indirect | · | Acquired | (price as of 2026-10-02) |
| June 13, 2018 | GYRE | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 18, 2018 | CYPH | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 14, 2017 | CYPH | P | 1,057,769 | · | · | 1,057,769 Indirect | · | Acquired | (price as of 2026-10-02) |
| Nov. 14, 2017 | CYPH | P | 1,057,769 | $6.08 | $6,431,236 | 3,573,376 Indirect | +42.05% | Acquired | -95.0% (price as of 2026-10-02) |
| July 13, 2017 | GYRE | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2017 | CYPH | A | 330,303 | · | · | 330,303 Direct | · | Acquired | (price as of 2026-10-02) |
| June 9, 2016 | GYRE | A | 7,500 | · | · | 7,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 22, 2015 | GYRE | A | 6,750 | · | · | 6,750 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 22, 2015 | GYRE | A | 6,750 | · | · | 6,750 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 22, 2015 | GYRE | A | 8,250 | · | · | 8,250 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 14,056 | · | · | 14,056 Indirect | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 11,383 | · | · | 11,383 Indirect | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 2,254 | · | · | 2,254 Indirect | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 1,041,024 | · | · | 1,041,024 Indirect | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 28, 2025 | CYPH | Restricted Stock Units | Common Stock | · | · | 22,500 | Disposed |
| Nov. 13, 2024 | CYPH | Warrant (Right to Buy) | Common Stock, $0.001 par value per share | $2.82 | Nov. 14, 2024 | 2,136 | Disposed |
| Oct. 2, 2024 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $2.45 | Oct. 2, 2034 | 85,000 | Acquired |
| Jan. 29, 2024 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $2.68 | Jan. 29, 2034 | 85,000 | Acquired |
| Jan. 26, 2024 | CYPH | Restricted Stock Units | Common Stock | · | · | 5,000 | Disposed |
| Aug. 23, 2023 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $2.21 | Aug. 23, 2033 | 70,000 | Acquired |
| March 31, 2023 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $0.34 | March 31, 2033 | 500,000 | Acquired |
| Sept. 1, 2022 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $1.43 | Aug. 31, 2032 | 200,000 | Acquired |
| Jan. 31, 2022 | CYPH | Restricted Stock Units | Common Stock | · | · | 225,000 | Acquired |
| June 9, 2021 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.55 | June 9, 2031 | 14,000 | Acquired |
| May 26, 2021 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $1.62 | May 25, 2031 | 30,000 | Acquired |
| Feb. 9, 2021 | CYPH | Warrant (Right to Buy) | Common Stock, $0.001 par value per share | $1.95 | Feb. 5, 2026 | 11,544 | Acquired |
| Feb. 9, 2021 | CYPH | Warrant (Right to Buy) | Common Stock, $0.001 par value per share | $1.95 | Feb. 5, 2026 | 571,428 | Disposed |
| Jan. 26, 2021 | CYPH | Restricted Stock Units | Common Stock | · | · | 50,000 | Acquired |
| Jan. 26, 2021 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $2.57 | Jan. 25, 2031 | 150,000 | Acquired |
| Aug. 10, 2020 | CYPH | Stock Option (Right to Buy) | Common Stock | $1.97 | Aug. 9, 2030 | 75,000 | Acquired |
| June 11, 2020 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.18 | June 11, 2030 | 5,000 | Acquired |
| April 9, 2020 | CYPH | Stock Option (Right to Buy) | Common Stock | $1.69 | April 9, 2030 | 50,000 | Acquired |
| June 13, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.46 | June 13, 2029 | 5,000 | Acquired |
| June 11, 2019 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $1.39 | June 10, 2029 | 200,000 | Acquired |
| Feb. 5, 2019 | CYPH | Warrant (Right to Buy) | Common Stock, $0.001 par value per share | $1.95 | Feb. 5, 2026 | 571,428 | Acquired |
| Jan. 1, 2019 | CYPH | Employee Stock Option (Right to Buy) | Common Stock | $2.00 | Dec. 31, 2028 | 50,000 | Acquired |
| July 30, 2018 | CYPH | Warrant (Right to Buy) | Common Stock | $6.08 | Nov. 14, 2024 | 21,369 | Acquired |
| June 13, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock | $24.94 | June 13, 2028 | 5,000 | Acquired |
| April 18, 2018 | CYPH | Stock Option (Right to Buy) | Common Stock, $0.001 par value per share | $7.66 | April 17, 2028 | 50,000 | Acquired |
| Nov. 14, 2017 | CYPH | Warrant (Right to Buy) | Common Stock, $0.001 par value per share | $6.08 | Nov. 14, 2024 | 1,057,769 | Acquired |
| July 13, 2017 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | July 13, 2027 | 10,000 | Acquired |
| Jan. 23, 2017 | CYPH | Stock Option (Right to Buy) | Common Stock, $0.001 par value per share | $9.90 | Jan. 22, 2027 | 330,303 | Acquired |
| June 9, 2016 | GYRE | Stock Option (Right to Buy) | Common Stock | $1.88 | June 9, 2026 | 7,500 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | Oct. 22, 2025 | 6,750 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | Oct. 22, 2025 | 6,750 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | Oct. 22, 2025 | 8,250 | Acquired |
| Aug. 20, 2015 | GYRE | Warrant (Right to Buy) | Common Stock | $3.33 | June 29, 2020 | 14,056 | Acquired |
| Aug. 20, 2015 | GYRE | Warrant (Right to Buy) | Common Stock | $3.33 | May 29, 2020 | 11,383 | Acquired |
| Aug. 20, 2015 | GYRE | Warrant (Right to Buy) | Common Stock | $33.27 | April 9, 2019 | 2,254 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $436,667 | · | $128,500 | $274,092 | $209,600 | · | $47,567 | $1,096,426 |
| 2020 | $400,000 | · | · | $141,841 | $168,000 | · | $41,511 | $751,352 |
| 2019 | $400,000 | · | · | $239,661 | $140,000 | · | $36,207 | $815,869 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.